PharmaCielo Ltd. (PCLOF)
OTCMKTS
· Delayed Price · Currency is USD
0.0433
+0.0022 (5.35%)
Jun 20, 2025, 9:53 AM EDT
PharmaCielo Revenue
In the year 2024, PharmaCielo had annual revenue of 3.48M CAD with 125.70% growth. PharmaCielo had revenue of 1.13M in the quarter ending December 31, 2024, with 361.82% growth.
Revenue
3.48M CAD
Revenue Growth
+125.70%
P/S Ratio
4.00
Revenue / Employee
n/a
Employees
n/a
Market Cap
9.68M USD
Revenue Chart
* This company reports financials in CAD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.48M | 1.94M | 125.70% |
Dec 31, 2023 | 1.54M | -3.77M | -70.96% |
Dec 31, 2022 | 5.31M | 3.36M | 172.93% |
Dec 31, 2021 | 1.94M | -708.92K | -26.71% |
Dec 31, 2020 | 2.65M | 1.87M | 237.26% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Jul 31, 2017 | Pro | Pro | Pro |
Jul 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Endo, Inc. | 1.73B |
Veradigm | 588.02M |
Elite Pharmaceuticals | 70.00M |
Tian'an Technology Group | 1.78M |
American Oncology Network | 1.76B |
Glass House Brands | 215.62M |
Northwest Biotherapeutics | 1.47M |
Silence Therapeutics | 27.70M |
PharmaCielo News
- 4 months ago - PharmaCielo Reports Q4 2024 Financial Results - Newsfile Corp
- 4 months ago - PharmaCielo Announces Issuance of Shares for Settlement of Certain Amounts Owing - Newsfile Corp
- 7 months ago - PharmaCielo Cannabis Co. Reports 270% YoY Increase In Q3 Revenue, Confident About Profitability In 2025 - Benzinga
- 7 months ago - PharmaCielo Reports Q3 2024 Financial Results - Newsfile Corp
- 8 months ago - PharmaCielo Announces Intention to Extend Expiry Date of Warrants - Newsfile Corp
- 8 months ago - Cannabis Flower Sales In Colombia And The Small Producer Protection Myth: Ex-Official Says Most Companies Qualify - Benzinga
- 9 months ago - PharmaCielo Announces Change to Financial Year-End, and Appointment of Davidson & Company LLP as Auditor Effective October 7, 2024 - Newsfile Corp
- 11 months ago - PharmaCielo GAAP EPS of -C$0.015, revenue of C$0.78M - Seeking Alpha